Berlin, Germany

Simon Michaelis

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Michaelis: Innovator in Medicinal Chemistry

Introduction

Simon Michaelis is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurological disorders. His work focuses on innovative solutions that address critical health challenges.

Latest Patents

Simon Michaelis holds a patent for "Bicyclic-compounds for use as a medicament, in particular for treatment of Parkinson's disease." This invention relates to novel small molecule compounds characterized by a basic structure that inhibits the enzyme Catechol-O-methyltransferase (COMT). The compounds exhibit a low off-target profile, making them promising candidates for the prevention or treatment of Parkinson's disease. He has 1 patent to his name.

Career Highlights

Throughout his career, Simon has worked with various organizations, contributing his expertise in medicinal chemistry. His innovative approach has led to advancements in the development of therapeutic agents. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Simon has collaborated with notable professionals, including Hubert Koester and Lisa Von Kleist. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Simon Michaelis is a distinguished inventor whose work in medicinal chemistry has the potential to impact the treatment of Parkinson's disease significantly. His innovative compounds represent a step forward in addressing complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…